Literature DB >> 12691632

Where do we go from here? Relations between the medical profession and the pharmaceutical industry.

Joseph S Alpert1.   

Abstract

Mesh:

Year:  2003        PMID: 12691632     DOI: 10.1007/s11886-003-0043-y

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


× No keyword cloud information.
  6 in total

1.  Full disclosure: the antidote to conflict of interest.

Authors:  W W Parmley
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

2.  Uneasy alliance--clinical investigators and the pharmaceutical industry.

Authors:  T Bodenheimer
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

3.  Is academic medicine for sale?

Authors:  M Angell
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

4.  Science and business. Conflicts of interest--moving beyond disclosure.

Authors:  T R Cech; J S Leonard
Journal:  Science       Date:  2001-02-09       Impact factor: 47.728

5.  Academic relationships with industry: a new model for biomedical research.

Authors:  H Moses; J B Martin
Journal:  JAMA       Date:  2001-02-21       Impact factor: 56.272

6.  Conflicts of interest: science, money, and health.

Authors:  Joseph S Alpert; Seymour Furman; Lynn Smaha
Journal:  Arch Intern Med       Date:  2002-03-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.